Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing etodolac (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing prostaglandin-endoperoxide synthase isoform 2 inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
1 |
Etodolac 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing precisely etodolac 300 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Etodolac 600mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Celecoxib 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing precisely celecoxib 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing celecoxib (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Etodolac 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Etodolac 400mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Etodolac 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Etodolac 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing valdecoxib (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Valdecoxib 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Valdecoxib 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Nabumetone (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Rofecoxib (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Meloxicam (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing parecoxib (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Parecoxib 40mg injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Parecoxib 40mg injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing etoricoxib (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Etoricoxib 60mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Etoricoxib 90mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Etoricoxib 120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Etoricoxib 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Etoricoxib 90 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Etoricoxib 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Parecoxib 40mg injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Parecoxib 40mg injection (pdr for recon)+diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Valdecoxib 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Celecoxib |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Etoricoxib (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Parecoxib (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Valdecoxib (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Deracoxib (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Firocoxib (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Lumiracoxib (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Nimesulide (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Parecoxib sodium (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Ketorolac trometamol |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Ketorolac (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Etodolac (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Nepafenac (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Ibuprofen sodium (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Ibuprofen (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Ibuprofen sodium dihydrate (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Ibuprofen lysine (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Dexibuprofen (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Dexketoprofen trometamol (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Dexketoprofen (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Naproxen sodium |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Naproxen (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Fenoprofen (substance) |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Fenoprofen calcium |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Alminoprofen |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|
Polmacoxib |
Is a |
True |
Substance with prostaglandin-endoperoxide synthase isoform 2 inhibitor mechanism of action (substance) |
Inferred relationship |
Some |
|